Slingshot members are tracking this event:
Allergen Submits Filing to FDA for the Generic Manufacturing and Marketing of Celgene's Abraxane - Celgene to Defend it's Patent Rights
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Mar 07, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Abbreviated New Drug Application, Fda, Abraxane, Patent Rights, Generic Drug